Home / Recalls / Watson Laboratories Inc / D-1400-2012

D-1400-2012 Class III Terminated

Recalled by Watson Laboratories Inc — Corona, CA

Recall Details

Product Type
Drugs
Report Date
July 11, 2012
Initiation Date
April 17, 2012
Termination Date
March 18, 2013
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
106,323 bottles

Product Description

Loxapine Capsules USP, 10mg, 100 count bottle, Rx only, Manufactured By: Watson Laboratories Inc., Corona, CA 92880 Rx only. NDC # 0591-0370-01

Reason for Recall

Labeling: Incorrect or Missing Package Insert: An outdated version of a patient outsert was used when packaged.

Distribution Pattern

Nationwide.

Code Information

Lot #s: 107886A, 107887A, 112874A, 144274A, 196483A, 201146A, 217265A, 260747B, 283308A, 313279A, 313279B, 327892A, 327893A, 327894A, 387239A, 387240A, 427259A, 427260A, 456251A.

Other recalls by Watson Laboratories Inc

  • D-1053-2014 Class II — Hydrocodone Bitartrate and Acetaminophen Tablets USP, CIII, 10 mg/ 660 mg, 100 c (January 15, 2014)
  • D-397-2014 Class II — Carisoprodol Tablets, USP, CIV, 350 mg, 500 count bottle, Rx only. Manufactured (December 23, 2013)
  • D-66360-001 Class II — Next Choice" One Dose Emergency Contraceptive (Levonorgestrel Tablet), 1.5 mg, 1 (September 23, 2013)
  • D-66251-001 Class II — Oxycodone and Acetaminophen Tablets, USP 10 mg/650 mg, CII, 100 Count Bottles, R (September 13, 2013)
  • D-1061-2013 Class III — Hydrocodone Bitartrate and Acetaminophen Tablets, 7.5 mg/650 mg Tablets, 500 Cou (August 30, 2013)
  • D-823-2013 Class III — Oxycodone and Acetaminophen Capsules, USP 5mg/500 mg, packaged in a)100-count bo (July 19, 2013)
  • D-205-2013 Class II — ZARAH¿ Drospirenone/ Ethinyl Estradiol Tablets, 3.0 mg/0.03 mg, Rx only, 3 table (February 13, 2013)
  • D-203-2013 Class II — Meprobamate, Tablets USP, 200 mg, 100 tablets; Rx only; Manufactured By: Watson (February 8, 2013)
  • D-204-2013 Class II — Meprobamate; Tablets USP, 400 mg, 100 tablets; Rx only; Manufactured By: Watson (February 8, 2013)
  • D-094-2013 Class III — Caziant (desogestrel and ethinyl estradiol) Tablets, USP, (Triphasic Regimen), 0 (December 13, 2012)